Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun 23;5(5-6):126-127.
doi: 10.18632/oncoscience.417. eCollection 2018 May.

A new concept in NF2 pharmacotherapy: targeting fatty acid synthesis

Affiliations
Editorial

A new concept in NF2 pharmacotherapy: targeting fatty acid synthesis

Dina S Stepanova et al. Oncoscience. .
No abstract available

Keywords: fatty acid synthesis; neurofibromatosis 2; small molecule inhibitors.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no potential conflicts of interest.

Figures

Figure 1
Figure 1. Differential effects of manipulating malonyl-coA levels in Nf2-null cells
(A) Small molecules that increase malonyl-CoA levels by increasing its synthesis or by reducing its catabolism; (B) Effect of chemical inhibition of PDK on cerulenin toxicity. The PDK inhibitor sodium dichloroacetate (50 mM) was added together with the indicated concentrations of cerulenin, 4 hours after cell seeding, and cells were then incubated for 48 hours. Experiments were repeated 3 times. Mean values and 95% confidence intervals are shown. MEF Nf2−/− - Nf2-knockout murine embryonic fibroblasts, MEF Nf-2f/f – wild-type murine embryonic fibroblasts, KT21 – malignant NF2-deficient human meningioma cells, Aco7 – normal human arachnoid cells.

References

    1. Ruggieri M, et al. Acta Otorhinolaryngol Ital. 2016;36:345–67. doi: 10.14639/0392-100X-1093. - DOI - PMC - PubMed
    1. Stepanova DS, et al. Cancer Res. 2017;77:5026–38. doi: 10.1158/0008-5472.CAN-16-2834. - DOI - PMC - PubMed
    1. Menendez JA, et al. Nat Rev Cancer. 2007;7:763–77. doi: 10.1038/nrc2222. - DOI - PubMed
    1. Garcia-Villafranca J, et al. Biochem Pharmacol. 2002;63:1997–2000. - PubMed
    1. Angeles TS, et al. Expert Opin Drug Discov. 2016;11:1187–99. doi: 10.1080/17460441.2016.1245286. - DOI - PubMed

Publication types

LinkOut - more resources